BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27380905)

  • 1. Characterizing amide proton transfer imaging in haemorrhage brain lesions using 3T MRI.
    Jeong HK; Han K; Zhou J; Zhao Y; Choi YS; Lee SK; Ahn SS
    Eur Radiol; 2017 Apr; 27(4):1577-1584. PubMed ID: 27380905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amid proton transfer (APT) and magnetization transfer (MT) MRI contrasts provide complimentary assessment of brain tumors similarly to proton magnetic resonance spectroscopy imaging (MRSI).
    Su C; Zhao L; Li S; Jiang J; Cai K; Shi J; Yao Y; Ao Q; Zhang G; Shen N; Hu S; Zhang J; Qin Y; Zhu W
    Eur Radiol; 2019 Mar; 29(3):1203-1210. PubMed ID: 30105412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy and uncertainty of asymmetric magnetization transfer ratio quantification for amide proton transfer (APT) imaging at 3T: a Monte Carlo study.
    Yuan J; Zhang Q; Wang YX; Wei J; Zhou J
    Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():5139-42. PubMed ID: 24110892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging acute ischemic tissue acidosis with pH-sensitive endogenous amide proton transfer (APT) MRI--correction of tissue relaxation and concomitant RF irradiation effects toward mapping quantitative cerebral tissue pH.
    Sun PZ; Wang E; Cheung JS
    Neuroimage; 2012 Mar; 60(1):1-6. PubMed ID: 22178815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amide Proton Transfer (APT) MR imaging and Magnetization Transfer (MT) MR imaging of pediatric brain development.
    Zhang H; Kang H; Zhao X; Jiang S; Zhang Y; Zhou J; Peng Y
    Eur Radiol; 2016 Oct; 26(10):3368-76. PubMed ID: 26762941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amide proton transfer imaging for differentiation of benign and atypical meningiomas.
    Joo B; Han K; Choi YS; Lee SK; Ahn SS; Chang JH; Kang SG; Kim SH; Zhou J
    Eur Radiol; 2018 Jan; 28(1):331-339. PubMed ID: 28687916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-Dimensional Gradient-Echo-Based Amide Proton Transfer-Weighted Imaging of Brain Tumors: Comparison With Two-Dimensional Spin-Echo-Based Amide Proton Transfer-Weighted Imaging.
    Murayama K; Ohno Y; Yui M; Yamamoto K; Ikedo M; Ohba S; Hanamatsu S; Iwase A; Ikeda H; Hirose Y; Toyama H
    J Comput Assist Tomogr; 2023 May-Jun 01; 47(3):494-499. PubMed ID: 37185016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amide proton transfer magnetic resonance imaging of Alzheimer's disease at 3.0 Tesla: a preliminary study.
    Wang R; Li SY; Chen M; Zhou JY; Peng DT; Zhang C; Dai YM
    Chin Med J (Engl); 2015 Mar; 128(5):615-9. PubMed ID: 25698192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amide proton transfer imaging of glioblastoma, neuroblastoma, and breast cancer cells on a 11.7 T magnetic resonance imaging system.
    Tanoue M; Saito S; Takahashi Y; Araki R; Hashido T; Kioka H; Sakata Y; Yoshioka Y
    Magn Reson Imaging; 2019 Oct; 62():181-190. PubMed ID: 31302222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades.
    Togao O; Yoshiura T; Keupp J; Hiwatashi A; Yamashita K; Kikuchi K; Suzuki Y; Suzuki SO; Iwaki T; Hata N; Mizoguchi M; Yoshimoto K; Sagiyama K; Takahashi M; Honda H
    Neuro Oncol; 2014 Mar; 16(3):441-8. PubMed ID: 24305718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated separation of diffusely abnormal white matter from focal white matter lesions on MRI in multiple sclerosis.
    Maranzano J; Dadar M; Zhernovaia M; Arnold DL; Collins DL; Narayanan S
    Neuroimage; 2020 Jun; 213():116690. PubMed ID: 32119987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B
    Kanazawa Y; Fushimi Y; Sakashita N; Okada T; Arakawa Y; Miyazaki M
    Magn Reson Med Sci; 2018 Jan; 17(1):86-94. PubMed ID: 28566586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.
    Debnath A; Gupta RK; Singh A
    Mol Imaging Biol; 2020 Apr; 22(2):384-396. PubMed ID: 31228076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amide proton transfer and chemical exchange saturation transfer MRI differentiates between growing and non-growing intracranial meningiomas: a pilot study.
    Koike H; Morikawa M; Ideguchi R; Uetani M; Hiu T; Matsuo T
    Clin Radiol; 2022 Apr; 77(4):e295-e301. PubMed ID: 35090693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.
    Jiang S; Yu H; Wang X; Lu S; Li Y; Feng L; Zhang Y; Heo HY; Lee DH; Zhou J; Wen Z
    Eur Radiol; 2016 Jan; 26(1):64-71. PubMed ID: 25925361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeatability of amide proton transfer-weighted signals in the brain according to clinical condition and anatomical location.
    Lee JB; Park JE; Jung SC; Jo Y; Kim D; Kim HS; Choi CG; Kim SJ; Kang DW
    Eur Radiol; 2020 Jan; 30(1):346-356. PubMed ID: 31338651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Magnetization Transfer Ratio Evolution in Multiple Sclerosis White Matter Lesions.
    Zheng Y; Lee JC; Rudick R; Fisher E
    J Neuroimaging; 2018 Mar; 28(2):191-198. PubMed ID: 29076591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histogram analysis of amide proton transfer-weighted imaging: comparison of glioblastoma and solitary brain metastasis in enhancing tumors and peritumoral regions.
    Kamimura K; Nakajo M; Yoneyama T; Fukukura Y; Hirano H; Goto Y; Sasaki M; Akamine Y; Keupp J; Yoshiura T
    Eur Radiol; 2019 Aug; 29(8):4133-4140. PubMed ID: 30488111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility of APT-weighted CEST-MRI at 3T in healthy brain and tumor across sessions and scanners.
    Wu Y; Wood TC; Derks SHAE; Pruis IJ; van der Voort S; van Zanten SEMV; Smits M; Warnert EAH
    Sci Rep; 2023 Oct; 13(1):18115. PubMed ID: 37872418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.